The Effects of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Volunteers: A Single-Sequence Crossover Study

por Garonzik, Samira, Byon, Wonkyung, Myers, Elsa, Li, Xiodong, Marchisin, David, Murthy, Bindu
Publicado 2019

Evaluation of safety, pharmacokinetics, and pharmacodynamics of apixaban in pediatric subjects at risk of venous or arterial thrombotic disorder

por Merali, Samira J., Byon, Wonkyung, Patel, Yogesh T., Elsrougy, Amira, Marchisin, David, Perera, Vidya, Chen, Weidong, He, Bing, Murthy, Bindu
Publicado 2023

Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Chinese Subjects

por Jing, Shan, Lin, Yang, Dockens, Randy, Marchisin, David, He, Bing, Girgis, Ihab G., Chimalakonda, Anjaneya, Murthy, Bindu, Aras, Urvi
Publicado 2023

Lack of Electrocardiographic Effects of Deucravacitinib in Healthy Subjects

por Chimalakonda, Anjaneya, Singhal, Shalabh, Darbenzio, Raymond, Dockens, Randy, Marchisin, David, Banerjee, Subhashis, Girgis, Ihab G., Throup, John, He, Bing, Aras, Urvi, Murthy, Bindu
Publicado 2022